Mariana Rodrigues Santesso

Mariana Rodrigues Santesso

Auto-generated profile, based on publicly available information

Mariana Rodrigues Santesso

Molecular Oncology Laboratory, Experimental Research Unit, Faculty of Medicine, São Paulo State University (UNESP), Botucatu 18618-687, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
CTCintia Kazuko Tokuhara
Cintia Kazuko Tokuhara
MSMariana Rodrigues Santesso
Mariana Rodrigues Santesso
GOGabriela Silva Neubern de Oliveira
Gabriela Silva Neubern de Oliveira
Talita Mendes Oliveira Ventura VenturaTalita Mendes Oliveira Ventura Ventura
Talita Mendes Oliveira Ventura Ventura
JDJulio Toshimi Doyama
Julio Toshimi Doyama
RORodrigo Oliveira
Rodrigo Oliveira
Bone development and healing processes involve a complex cascade of biological events requiring well-orchestrated synergism with bone cells, growth factors, and other trophic signaling molecules and cellular structures. Beyond health processes, MMPs play several key roles in the installation of heart and blood vessel related diseases and cancer, ranging from accelerating metastatic cells to ectopic vascular mineralization by smooth muscle cells in complementary manner. The tissue inhibitors of MMPs (TIMPs) have an important role in controlling proteolysis. Paired with the post-transcriptional efficiency of specific miRNAs, they modulate MMP performance. If druggable, these molecules are suggested to be a platform for development of “smart” medications and further clinical trials. Thus, considering the pleiotropic effect of MMPs on mammals, the purpose of this review is to update the role of those multifaceted proteases in mineralized tissues in health, such as bone, and pathophysiological disorders, such as ectopic vascular calcification and cancer.

24 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
VSVanessa G. P. Souza
Vanessa G. P. Souza
RARachel Paes de Araújo
Rachel Paes de Araújo
MSMariana R. Santesso
Mariana R. Santesso
ASAna Laura Seneda
Ana Laura Seneda
Iael Weissberg MinutentagIael Weissberg Minutentag
Iael Weissberg Minutentag
PRPatricia Reis
Patricia Reis
Lung cancer is one of the most frequent tumors that metastasize to the brain. Brain metastasis (BM) is common in advanced cases, being the major cause of patient morbidity and mortality. BMs are thought to arise via the seeding of circulating tumor cells into the brain microvasculature. In brain tissue, the interaction with immune cells promotes a microenvironment favorable to the growth of cancer cells. Despite multimodal treatments and advances in systemic therapies, lung cancer patients still have poor prognoses. Therefore, there is an urgent need to identify the molecular drivers of BM and clinically applicable biomarkers in order to improve disease outcomes and patient survival. The goal of this review is to summarize the current state of knowledge on the mechanisms of the metastatic spread of lung cancer to the brain and how the metastatic spread is influenced by the brain microenvironment, and to elucidate the molecular determinants of brain metastasis regarding the role of genomic and transcriptomic changes, including coding and non-coding RNAs. We also present an overview of the current therapeutics and novel treatment strategies for patients diagnosed with BM from NSCLC.